Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Palliative Care
Published in: BMC Palliative Care 1/2021

Open Access 01-12-2021 | Care | Research

Palliative Performance Scale and survival in patients with cancer and non-cancer diagnoses needing a palliative care consultation: a retrospective cohort study

Authors: Patcharaporn Prompantakorn, Chaisiri Angkurawaranon, Kanokporn Pinyopornpanish, Lalita Chutarattanakul, Chanchanok Aramrat, Chanapat Pateekhum, Nisachol Dejkriengkraikul

Published in: BMC Palliative Care | Issue 1/2021

Login to get access

Abstract

Background

Palliative Performance Scale (PPS) has been frequently used to estimate the survival time of palliative care patients. The objective was to determine the associations between the PPS and survival time among cancer and non-cancer patients in Thailand.

Methods

This is a retrospective cohort study. All in-patient adults who received a palliative care consultation at Chiang Mai University Hospital between 1 July 2018 to 31 July 2019 were included in the study and were followed-up until 26 June 2020. The Palliative Performance Scale was assessed using the validated Thai-Palliative Performance Scale for Adults. Survival analysis was used to determine the association between the Palliative Performance Scale and survival time among cancer and non-cancer patients.

Results

Out of 407 patients, 220 were male (54.1%). There were 307 cancer patients (75.4%) and 100 non-cancer patients (24.6%). The PPS and survival time in cancer patients were significantly correlated. Cancer patients with PPS 10, 20, 30, 40–60, and 70–80% had a median survival time of 2, 6, 13, 39, and 95 days, respectively. Non-cancer patients with PPS 10, 20, and 30% had a median survival time of 8, 6, and 24 days, respectively.

Conclusions

While useful for estimating survival time for cancer patients, other factors should be taken into account in estimating the survival time for non-cancer patients.
Appendix
Available only for authorised users
Literature
1.
2.
Chan E-Y, Wu H-Y, Chan Y-H. Revisiting the Palliative Performance Scale: change in scores during disease trajectory predicts survival. Palliat Med. 2013;27:367–74.CrossRef
3.
Jansen WJJ, Buma S, Gootjes JRG, et al. The palliative performance scale applied in high-care residential hospice: a retrospective study. Palliat Med. 2015;18:67–70.CrossRef
4.
Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005; 23: 6240–6248. 2005/09/02.
5.
Boyd K and Murray SA. Recognising and managing key transitions in end of life care. BMJ 2010; 341.
6.
Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ (Clinical Research Ed). 2005;330:1007–11.CrossRef
7.
Quinn KL, Stukel T, Stall NM, et al. Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study. BMJ. 2020;370:m2257.CrossRef
8.
Pinyopornpanish K, Angkurawaranon C, Gomutbutra P, et al. Factors affecting family members’ decisions to reveal cancer diagnoses to patients: A qualitative study. J Med Assoc Thai. 2017;100:808–14.
9.
Simmons CPL, McMillan DC, McWilliams K, et al. Prognostic tools in patients with advanced cancer: a systematic review. J Pain Symptom Manage. 2017;53:962–70.CrossRef
10.
Jang RW, Caraiscos VB, Swami N, et al. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract 2014; 10: e335–341. 2014/08/15. con
11.
Chewaskulyong B, Sapinun L, Downing GM, et al. Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2). Palliat Med 2012; 26: 1034–1041. 2011/10/14.
12.
Anderson F, Downing GM, Hill J, et al. Palliative performance scale (PPS): a new tool. J Palliat Care 1996; 12: 5–11. 1996/01/01.
13.
Baik D, Russell D, Jordan L, et al. Using the palliative performance scale to estimate survival for patients at the end of life: a systematic review of the literature. Palliat Med. 2018;21:1651–61.CrossRef
14.
Lau F, Downing M, Lesperance M, et al. Using the Palliative Performance Scale to provide meaningful survival estimates. J Pain Symptom Manage. 2009;38:134–44.CrossRef
15.
Head B, Ritchie CS, Smoot TM. Prognostication in Hospice Care: Can the Palliative Performance Scale Help? Palliat Med. 2005;8:492–502.CrossRef
16.
Lau F, Maida V, Downing M, et al. Use of the Palliative Performance Scale (PPS) for end-of-life prognostication in a palliative medicine consultation service. J Pain Symptom Manage. 2009;37:965–72.CrossRef
17.
18.
Weng LC, Huang HL, Wilkie DJ, et al. Predicting survival with the Palliative Performance Scale in a minority-serving hospice and palliative care program. J Pain Symptom Manage 2009; 37: 642–648. 2008/10/01.
19.
Yoon SJ, Choi SE, LeBlanc TW, et al. Palliative Performance Scale Score at 1 Week After Palliative Care Unit Admission is More Useful for Survival Prediction in Patients With Advanced Cancer in South Korea. Am J Hosp Palliat Care 2018; 35: 1168–1173. 2018/04/18.
20.
Mei AH, Jin WL, Hwang MK, et al. Value of the Palliative Performance Scale in the prognostication of advanced cancer patients in a tertiary care setting. Palliat Med 2013; 16: 887–893. 2013/06/14.
21.
Venketasubramanian N, Yoon BW, Pandian J, et al. Stroke Epidemiology in South, East, and South-East Asia: A Review. J Stroke 2017; 19: 286–294. 2017/09/29.
22.
Cohen-Mansfield J, Skornick-Bouchbinder M, Brill S. Trajectories of End of Life: A Systematic Review. J Gerontol B Psychol Sci Soc Sci: Series B. 2018;73:564–72.CrossRef
23.
Bostwick D, Wolf S, Samsa G, et al. Comparing the palliative care needs of those with cancer to those with common non-cancer serious illness. J Pain Symptom Manage. 2017;53:1079–84.CrossRef
24.
Stevenson J, Abernethy AP, Miller C, et al. Managing comorbidities in patients at the end of life. BMJ. 2004;329:909–12.CrossRef
Metadata
Title
Palliative Performance Scale and survival in patients with cancer and non-cancer diagnoses needing a palliative care consultation: a retrospective cohort study
Authors
Patcharaporn Prompantakorn
Chaisiri Angkurawaranon
Kanokporn Pinyopornpanish
Lalita Chutarattanakul
Chanchanok Aramrat
Chanapat Pateekhum
Nisachol Dejkriengkraikul
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Care
Published in
BMC Palliative Care / Issue 1/2021
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-021-00773-8

Other articles of this Issue 1/2021

BMC Palliative Care 1/2021 Go to the issue

Research

Validity and reliability of the English and translated Chinese versions of the Integrated Palliative care Outcome Scale (IPOS) in Singapore

Research

Same, same, but different? A longitudinal, mixed-methods study of stability in values and preferences for future end-of-life care among community-dwelling, older adults

Research

Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico

Research

Health professionals’ perceptions of palliative care for end-stage cardiac and respiratory conditions: a qualitative interview study

Research article

Development of a managed clinical network for children’s palliative care – a qualitative evaluation

Research Article

Short-form quality care questionnaire-palliative care has acceptable measurement properties in Brazilian cancer patients